Back to Search
Start Over
Successful treatment with adapted high dose methotrexate in a hemodialysis patient with primary central nervous system lymphoma: 100mg/m2seems sufficient
- Source :
- Nefrología; March-April 2022, Vol. 42 Issue: 2 p130-134, 5p
- Publication Year :
- 2022
-
Abstract
- High dose methotrexate (HD-MTX) based chemoimmunotherapy is a central part of the standard approach to treatment of primary central nervous system lymphoma (PCNSL). Renal dysfunction leads to delayed MTX complete elimination and critical MTX concentration. Despite the recommendations, hemodialysis status should not exclude HD-MTX.
Details
- Language :
- English
- ISSN :
- 02116995 and 19892284
- Volume :
- 42
- Issue :
- 2
- Database :
- Supplemental Index
- Journal :
- Nefrología
- Publication Type :
- Periodical
- Accession number :
- ejs56264297
- Full Text :
- https://doi.org/10.1016/j.nefro.2021.03.004